V7A (p.Val7Ala) variant of CDKN2A (Tumor suppressor ARF)

V7A (p.Val7Ala) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Familial melanoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes population frequency data, published literature, and structural context.

V7A (p.Val7Ala) variant details